Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Insulin Aspart
100%
Clinical Application
100%
Insulin Degludec
100%
Co-formulation
100%
Degludec Aspart
100%
Type 2 Diabetes Mellitus (T2DM)
57%
Insulin Dose
57%
Premixed Insulin
57%
Insulin
42%
Once-daily
42%
Glycemic Control
28%
Low Risk
14%
AIMS™
14%
Hypoglycemia
14%
Type 1 Diabetes Mellitus (T1DM)
14%
Insulin Therapy
14%
Hemoglobin A1c (HbA1c)
14%
Low Dose Rate
14%
Twice Daily
14%
Once-daily Dosing
14%
Nave
14%
Postprandial Insulin
14%
Pharmacodynamics
14%
Clinical Evidence
14%
Long-acting Insulin
14%
Basal Insulin
14%
Type 1 and Type 2 Diabetes Mellitus
14%
Twice-daily Dosing
14%
Prandial
14%
Molecular Structure
14%
Glucose Control
14%
Nocturnal Hypoglycemia
14%
Premixed
14%
Basal-bolus
14%
Inflexibility
14%
Mealtime Insulin
14%
Insulin Preparations
14%
Injection Timing
14%
Medicine and Dentistry
Insulin Aspart
100%
Insulin Degludec
100%
Type 2 Diabetes
57%
Insulin
42%
Glycemic Control
28%
Maturity Onset Diabetes of the Young
14%
Hemoglobin A1c
14%
Hypoglycemia
14%
Long Acting Insulin
14%
Insulin Treatment
14%
Meal
14%
Pharmacodynamics
14%
Type 1 Diabetes
14%
Flexibility
14%
Nocturnal Hypoglycemia
14%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Aspart
100%
Insulin Degludec
100%
Insulin Analog
42%
Hypoglycemia
14%
Hemoglobin A1c
14%
Non Insulin Dependent Diabetes Mellitus
14%
Long Acting Insulin
14%
Pharmacodynamics
14%
Nocturnal Hypoglycemia
14%